BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Forensic DNA experts to gather for 30th International Symposium on Human Identification (ISHI) Sept. 23-26 in Palm Springs

  Bureau Veritas, a world-leader in testing, inspection, and certification (TIC) services, today announced it has met rigorous ISO 17025 standards to become the first Canadian laboratory to receive accreditation for eDNA testing from the Standards Council of Canada.

  August 21, 2019

   · 

  3 min read
• Business

  Shield Diagnostics Appoints David Esposito to its Board of Directors

  Shield Diagnostics, an Andreessen Horowitz-backed biotechnology company tackling antibiotic resistance by bringing precision medicine to infectious disease, announced today that it has appointed David Esposito to its Board of Directors.

  August 21, 2019

   · 

  2 min read
• Business

  CureDuchenne Taps Erin Frey to Lead Advocacy Efforts for Duchenne Muscular Dystrophy

  CureDuchenne announced it has tapped Erin Frey as Senior Director of Advocacy.

  August 21, 2019

   · 

  3 min read
• Business

  Innovent Enters a Licensing Agreement with Lilly to Develop & Commercialize a Novel Diabetes Medicine in China

  Innovent Biologics, Inc. announced that it has entered into a licensing agreement with Eli Lilly and Company for the development and potential commercialization of oxyntomodulin analog, OXM3, in China.

  August 21, 2019

   · 

  3 min read
• Business

  CMAB and Kintor Announce a New Comprehensive Collaboration to Develop and Manufacture the ALK-1 Monoclonal Antibody

  CMAB Biopharma (Suzhou) Inc. (“CMAB”), a pure-play CDMO business in biologics and Suzhou Kintor Pharmaceuticals, Inc. (“Kintor”), an innovative biopharmaceutical enterprise, announced a comprehensive strategic cooperation agreement for the development and manufacturing of Kintor’s ALK-1 mAb.

  August 21, 2019

   · 

  6 min read
• Biotech Beach

  PharmaCyte Biotech to Hold Special Shareholder Meeting

  The shareholder meeting, not to be confused with a shareholder conference call, will be held at the Courtyard by Marriott in Irvine, California, and will begin at 11:00 a.m. Pacific Daylight Time.

  August 21, 2019

   · 

  4 min read
• Reducing Excess Inventory Costs and Material Spend for a Medical Equipment Company | A Spend Analysis Engagement by SpendEdge

  SpendEdge, a leading provider of procurement market intelligence solutions, has announced the completion of their latest spend analysis engagement for a medical equipment company.

  August 21, 2019

   · 

  2 min read
• Business

  Appili Therapeutics Reports Financial Results for First Quarter of Fiscal Year 2020

  Appili Therapeutics Inc. (TSXV: APLI) (the “Company” or “Appili”), a biopharmaceutical company focused on anti-infective drug development, today reported its financial and operational results for the first quarter of its fiscal year 2020, which ended June 30, 2019.

  August 21, 2019

   · 

  5 min read
• Drug Development

  BioInvent Will Conduct Phase l/lla Trial With BI-1206 in Combination With Pembrolizumab (Keytruda) in Solid Tumors

  BioInvent International AB announced that the earlier communicated phase l/lla clinical trial in solid cancer will be conducted with BI-1206, one of BioInvent’s proprietary anti-FcγRllB antibodies, in combination with pembrolizumab, a leading anti-PD1 antibody.

  August 21, 2019

   · 

  3 min read
• Job Trends

  A Force for Change: DaVita Continues to Prioritize Environmental Sustainability

  DaVita Kidney Care, celebrated its 2019 sustainability milestones

  August 21, 2019

   · 

  4 min read